Funded Project Details - FY2021
|Title:|| Early Detection of HCC Among Veterans With Liver Cirrhosis|
||New Orleans, LA
|Congressional District Code:
||Biomedical Laboratory R&D
|| July 2019 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
Hepatocellular carcinoma (HCC) is a primary malignant cancer of the liver that most often develops in the background of liver cirrhosis (1,2). Hepatitis C virus (HCV) infection remains the major cause of liver cirrhosis and HCC among US Veterans (3,4). Recent advances in antiviral treatment have allowed an increasing number of cirrhotic patients to be cured with interferon (IFN)-free direct-acting antivirals (DAAs) (5,6). In the coming years, hepatitis C eradication is expected to decrease, but...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.